Use of Information and Communication Technologies in Motor Rehabilitation of Patients with Stroke
Main Article Content
Abstract
Stroke is an acute violation of cerebral circulation, which is one of the main causes of disability and mortality in the population. In addition to its unconditional medical and social significance, a stroke also brings colossal economic damage. For example, in the United States, costs associated with the treatment and rehabilitation of patients with stroke, as well as economic losses associated with disability, amount to 6.5-11.2 billion dollars per year. The problem of stroke is especially urgent in the Russian Federation, where 450 thousand cases of strokes are registered annually and for every 100 thousand of the population there are 600 patients with the consequences of stroke, of which 60% remain disabled [2, 9].
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Alon D, Stein GY, Korenfeld R, Fuchs S. Predictors and outcomes of infection-related hospital admissions of heart failure patients. PLoS One. 2013 Aug 23;8(8):e72476. doi:10.1371/journal.pone.0072476. eCollection 2013.
II. Alrawaiq N., Abdullah A. (2014) A review of flavonoid quercetin: metabolism, bioactivity and antioxidant properties. Int. J. Pharm. Tech. Res., 6(3): 933-941.
III. Anderson D., Larson D., Bluhm J. et al. Diagnosis and Initial Treatment of Ischemic Stroke. Updated July 2012. Institute for Clinical Systems Improvement. - 122 p. - www.icsi.org. – Последнеепосещениесайта 02.06.13.
IV. Arentz M, Yim E, Klaff L, et al. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA. 2020 Mar 19. doi:10.1001/jama.2020.4326. [Epub ahead of print].
V. ASE Statement on Protection of Patients and Echocardiography Service Providers During the 2019 Novel Coronavirus Outbreak. ASEcho.org
VI. Bachmetov L., Gal-Tanamy M., Shapira A. et al. (2012) Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity. J. Viral. Hepat., 19: 81-88.
VII. Bach-y-Rita P. Neural aspects of motor function as a basis of early and postacute rehabilitation / P. Bach-y-Rita, A. Brown, J. Lazarus [et al.] // In: Rehabilitation medicine; principles and practice. — 1993. — P. 381-403.
VIII. Bergmark A. Stability of the lumbar spine. A study in mechanical engineering // Acta Orthopaedica Scandinavica, 1989.
IX. Caramia M.D. Ipsilateral activation of the unaffected motor cortex in patients with hemiparetic stroke / M.D. Caramia, M.G. Palmieri, P. Giacomoni [et al.] // Clin. Neurophysiol. — 2000. — Vol. 111. — P. 1990-1996.
X. Colborne G.R. Feedback of ankle joint angle and soleus electromyography in the rehabilitation of hemiplegic gait / G.R. Colborne, S.J. Olney, M.P. Griffin // Arch. Phys. Med. Rehabil. — 1993. — Vol. 74. — P. 1100-1106.
XI. Dromerick A.W. Does the application of constraint-induced movement therapy during acute rehabilitation reduce arm impairment after stroke? / A.W. Dromerick, D.F. Edwards, M. Hahn // Stroke. — 2000. — Vol. 31. — P. 2984-2988.
XII. Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack. The European Stroke Organization (ESO), 2008. – 120 с. – http://www.eso-stroke.org – Последнеепосещениесайта 02.06.2013.
XIII. Hesse S. Restoration of gait in nonambulatoryhemiparetic patients by treadmill training with partial bodyweight support / S. Hesse, C. Bertelt, A. Schaffrin [et al.] // Arch. Phys. Med. Rehabil. — 1994. — Vol. 75. — P. 1087-1093.
XIV. Jauch E.C., Saver J.L., Adams H.P. et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke // Stroke. – 2013. – Vol. 44. P. 870-947.
XV. Kosak M.C. Comparison of partial body weight-supported treadmill gait training versus aggressive bracing assisted walking post stroke / M.C. Kosak, M.J. Reding // Neurorehabil. Neural. Repair. — 2000. — Vol. 14. — P. 13-19.
XVI. Rossi A. Imaging of acute encephalomyelitis. Neuroimaging Clinics. 18 (1):149-161.
XVII. Schleenbaker R.E. Electromyographic biofeedback for neuromuscular reeducation in the hemiplegic stroke patient: a meta-analysis / R.E. Schleenbaker, A.G. Mainous // Arch. Phys. Med. Rehabil. — 1993. — Vol. 74. — P. 1301-1304.
XVIII. Taub E. Technique to improve chronic motor deficit after stroke / E. Taub, N.E. Miller, T.A. Novack [et al.] // Arch. Phys. Med. Rehabil. — 1993. — Vol. 74. — P. 347-354.
XIX. Veizovic, T. Resolution of stroke deficits following contralateral grafts of conditionally immortal neuroepithelial stem cells / T. Veizovic, J.S. Beech, R.P. Stroemer [et al.] // Stroke. — 2001. — Vol. 32. — P. 1012-1019.
XX. Volpe B.T. Robot training enhanced motor outcome in patients with stroke maintained over 3 years / B.T. Volpe, H.I. Krebs, N. Hogan [et al.] // Neurology. — 1999. — Vol. 53. — P. 1874-1876.
XXI. Инсульт: диагностика, лечение, профилактика. Под редакцией З.А. Суслиной, М.А. Пирадова. – М.: МЕДпресс-информ, 2008. – 288 с.
XXII. Кадыков А.С. Реабилитация неврологических больных / А.С. Кадыков, Л.А. Черникова, Н.В. Шахпаронова. — М.: МЕДпресс-информ, 2008. — 560 с.
XXIII. Кардиоваскулярная профилактика. Национальные рекомендации. – Москва, 2011. – 64 стр. – http://www.scardio.ru – Последнее посещение сайта 02.06.2013.
XXIV. Кузнецов А.Н. Ишемический инсульт и транзиторные ишемические атаки / А.Н. Кузнецов, В.И. Скворцова, Л.В. Стаховская, З.А. Суслина / Клинические рекомендации. Неврология и нейрохирургия [под.ред. Е.И Гусева, А.Н. Коновалова, А.Б. Гехт]. — М.: ГЭОТАР-Медиа, 2007. — С. 129-177.
XXV. Маджидова Я.Н., Усманова Д.Д. Участие нейротрофического белка S100 и основного белка миелина в патогенезе развития хронической ишемии мозга. Сибирское медицинское обозрение// Красноярск № 1(103) 2017 г, С. 60-63
XXVI. Неврология: национальное руководство / Под редакцией Е.И. Гусева, А.Н. Коновалова, В.И. Скворцовой, А.Б. Гехт. – М.: ГЭОТАР-Медиа, 2010. – 1040 с.